Foot-and-mouth disease vaccines: recent updates and future perspectives

被引:48
作者
Kamel, Mohamed [1 ]
El-Sayed, Amr [1 ]
Castaneda Vazquez, Hugo [2 ]
机构
[1] Cairo Univ, Fac Vet Med, Dept Med & Infect Dis, Giza, Egypt
[2] Univ Guadalajara, Div Vet Sci, Lab Mastitis & Mol Diagnost, Guadalajara, Jalisco, Mexico
关键词
EXPRESSING CAPSID PROTEINS; PRECURSOR POLYPEPTIDE P1; T-CELL EPITOPES; DNA VACCINE; IMMUNE-RESPONSES; VP1; PROTEIN; VIRUS FMDV; PSEUDORABIES VIRUS; PARTIAL PROTECTION; ANTIBODY-RESPONSE;
D O I
10.1007/s00705-019-04216-x
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Foot-and-mouth disease (FMD) is a major worldwide viral disease in animals, affecting the national and international trade of livestock and animal products and leading to high economic losses and social consequences. Effective control measures of FMD involve prevention through vaccination with inactivated vaccines. These inactivated vaccines, unfortunately, require short-term protection and cold-chain and high-containment facilities. Major advances and pursuit of hot topics in vaccinology and vectorology are ongoing, involving peptide vaccines, DNA vaccines, live vector vaccines, and novel attenuated vaccines. DIVA capability and marker vaccines are very important in differentiating infected animals from vaccinated animals. This review focuses on updating the research progress of these novel vaccines, summarizing their merits and including ideas for improvement. HighlightsShortcomings of current vaccination strategiesPromising novel vaccines for FMD eradicationReverse genetics and new molecular technologies leading to vaccine improvementMarker vaccines and FMD control policyImmunoregulatory gene addition and FMD vaccine immunogenicity
引用
收藏
页码:1501 / 1513
页数:13
相关论文
共 136 条
  • [1] The pathogenesis and diagnosis of foot-and-mouth disease
    Alexandersen, S
    Zhang, Z
    Donaldson, AI
    Garland, AJM
    [J]. JOURNAL OF COMPARATIVE PATHOLOGY, 2003, 129 (01) : 1 - 36
  • [2] Aspects of the persistence of foot-and-mouth disease virus in animals - the carrier problem
    Alexandersen, S
    Zhang, ZD
    Donaldson, AI
    [J]. MICROBES AND INFECTION, 2002, 4 (10) : 1099 - 1110
  • [3] The Pathogenesis of Foot-and-Mouth Disease II: Viral Pathways in Swine, Small Ruminants, and Wildlife; Myotropism, Chronic Syndromes, and Molecular Virus-Host Interactions
    Arzt, J.
    Baxt, B.
    Grubman, M. J.
    Jackson, T.
    Juleff, N.
    Rhyan, J.
    Rieder, E.
    Waters, R.
    Rodriguez, L. L.
    [J]. TRANSBOUNDARY AND EMERGING DISEASES, 2011, 58 (04) : 305 - 326
  • [4] The Early Pathogenesis of Foot-and-Mouth Disease in Cattle After Aerosol Inoculation: Identification of the Nasopharynx as the Primary Site of Infection
    Arzt, J.
    Pacheco, J. M.
    Rodriguez, L. L.
    [J]. VETERINARY PATHOLOGY, 2010, 47 (06) : 1048 - 1063
  • [5] ARZT J, 2018, TRANSMISSION, V3, DOI DOI 10.1128/MSPHERE.00365-18
  • [6] BACHRACH HL, 1975, J IMMUNOL, V115, P1636
  • [7] BINARY ETHYLENIMINE AS AN INACTIVANT FOR FOOT-AND-MOUTH-DISEASE VIRUS AND ITS APPLICATION FOR VACCINE PRODUCTION
    BAHNEMANN, HG
    [J]. ARCHIVES OF VIROLOGY, 1975, 47 (01) : 47 - 56
  • [8] Safety profile of a replication-deficient human adenovirus-vectored foot-and-mouth disease virus serotype A24 subunit vaccine in cattle
    Barrera, J.
    Brake, D. A.
    Kamicker, B. J.
    Purcell, C.
    Kaptur, R., Jr.
    Schieber, T.
    Lechtenberg, K.
    Miller, T. D.
    Ettyreddy, D.
    Brough, D. E.
    Butman, B. T.
    Colby, M.
    Neilan, J. G.
    [J]. TRANSBOUNDARY AND EMERGING DISEASES, 2018, 65 (02) : 447 - 455
  • [9] Use of ENABL® adjuvant to increase the potency of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine
    Barrera, Jose
    Schutta, Christopher
    Pisano, Melia
    Grubman, Marvin J.
    Brake, David A.
    Miller, Timothy
    Kamicker, Barbara J.
    Olutunmbi, Femi
    Ettyreddy, Damodar
    Brough, Douglas E.
    Butman, Bryan T.
    Neilan, John G.
    [J]. VACCINE, 2018, 36 (08) : 1078 - 1084
  • [10] Development and performance of inactivated vaccines against foot and mouth disease
    Barteling, SJ
    [J]. REVUE SCIENTIFIQUE ET TECHNIQUE-OFFICE INTERNATIONAL DES EPIZOOTIES, 2002, 21 (03): : 577 - 588